Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Smith: Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle.... (0.10 sec) 

Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle …

- diabetesjournals.org
SR Smith, LJ Aronne, CM Burns, NC Kesty, … - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—At month 4, mean weight loss from baseline in the pramlintide arms
ranged from 3.8 ± 0.7 to 6.1 ± 0.8 kg (2.8 ± 0.8 kg with placebo). By month
12, initial 4-month weight loss was regained in the placebo group but was ...
Cited by 7 - Related articles - All 6 versions

Role of islet-, gut-, and adipocyte-derived hormones in the central control of food intake …


HC Chen, JD Roth, BE Schroeder, C Weyer - Current Diabetes Reviews, 2008 - ingentaconnect.com
Abstract: Contrary to its historical epithet as a lifestyle disorder, obesity is
now widely recognized as having a neurobi- ological basis. This progress is due
to our knowledge not only about energy homoeostatic pathways within the ...
Cited by 6 - Related articles - All 2 versions

Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude …

- endojournals.org
JL Trevaskis, T Coffey, R Cole, C Lei, C … - Endocrinology, 2008 - Endocrine Soc
Previously, we reported that combination treatment with rat amylin (100
µg/kg·d) and murine leptin (500 µg/kg·d) elicited greater inhibition of food
intake and greater body weight loss in diet-induced obese rats than ...
Cited by 5 - Related articles - All 6 versions

Implications of amylin receptor agonism: integrated neurohormonal mechanisms and …


JD Roth, H Maier, S Chen, BL Roland - Archives of Neurology, 2009 - Am Med Assoc
Amylin receptor agonism is emerging as part of an integrated neurohormonal
therapeutic approach for managing diabetes mellitus (DM) and body weight.
Pramlintide acetate, an analogue of the pancreatic hormone amylin, has been ...
Cited by 2 - Related articles - All 3 versions

[CITATION] Integrated neurohormonal approaches to the treatment of obesity: the amylin agonist …


JD Roth, C Mack, NC Kesty, DG Parkes, C … - Handbook of Obesity: Clinical Applications. 3rd ed. …, 2008
Cited by 4 - Related articles

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of …

- physiology.org
SR Smith, JE Blundell, C Burns, C Ellero, … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc
Evidence from rodent studies indicates that the -cell-derived neurohormone
amylin exerts multiple effects on eating behavior, including reductions in meal
size, intake of highly palatable foods, and stress-induced sucrose ...
Cited by 17 - Related articles - BL Direct - All 6 versions

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food …

- physiology.org
C Mack, J Wilson, J Athanacio, J Reynolds, K … - … Journal of Physiology- Regulatory, Integrative and …, 2007 - Am Physiological Soc
The ability of amylin to reduce acute food intake in rodents is well
established. Longer-term administration in rats (up to 24 days) shows a
concomitant reduction in body weight, suggesting energy intake plays a ...
Cited by 11 - Related articles - BL Direct - All 7 versions

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from …

- pnas.org
JD Roth, BL Roland, RL Cole, JL Trevaskis, … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences
Body weight is regulated by complex neurohormonal interactions between endocrine
signals of long-term adiposity (eg, leptin, a hypothalamic signal) and
short-term satiety (eg, amylin, a hindbrain signal). We report that ...
Cited by 31 - Related articles - BL Direct - All 6 versions

What are the risks and the benefits of current and emerging weight-loss medications?


JR Robinson, KD Niswender - Current Diabetes Reports, 2009 - Springer
Obesity is epidemic; new medications and therapeutic options are urgently needed
to reduce the assoc iated health care burden. The initial clinical strategy for
weight loss is lifestyle modification involving a combination of diet, ...
Related articles - All 2 versions

Gut peptides: targets for antiobesity drug development?


TH Moran, MJ Dailey - Endocrinology, 2009 - Endocrine Soc
Gut peptides play multiple roles in the controls of gastrointestinal function
and in the initiation and termination of meals. Plasma levels of these peptides
are differentially affected by the presence of nutrients in the digestive ...
Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google